CNS Pharmaceuticals, Inc
Advertisement
CNS Pharmaceuticals, Inc. is a Houston-based biopharmaceutical company that specializes in the development of innovative treatments for brain cancer. Their lead drug, Berubicin, has shown promising results in crossing the blood-brain barrier and effectively killing brain tumor cells that are typically resistant to other therapies.
With a focus on glioblastoma, the most aggressive form of brain cancer, CNS Pharmaceuticals aims to provide a potential breakthrough in treatment options for patients facing this devastating disease. Their research and development efforts are centered around Berubicin, an anthracycline-based drug that has demonstrated significant clinical response in Phase 1 trials, offering hope for improved outcomes and extended survival rates.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement
